Advantage 400 Spot-on Solution for Dogs

Šalis: Didžioji Britanija

kalba: anglų

Šaltinis: VMD (Veterinary Medicines Directorate)

Veiklioji medžiaga:

Imidacloprid

Prieinama:

Bayer plc

ATC kodas:

QP53AX17

INN (Tarptautinis Pavadinimas):

Imidacloprid

Vaisto forma:

Spot-on solution

Recepto tipas:

NFA-VPS - Non-Food Animal – Veterinarian, Pharmacist, Suitably Qualified Person

Farmakoterapinė grupė:

Dogs

Gydymo sritis:

Ectoparasiticide

Autorizacija statusas:

Authorized

Leidimo data:

1999-01-25

Prekės savybės

Revised: October 2019
AN: 00311/2019
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Advantage 400 Spot-on solution for Dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Imidacloprid 400 mg/pipette (4.0 ml of a 10 % solution)
EXCIPIENT(S):
Butylhydroxytoluene (E 321)
4.0 mg/pipette
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Spot-on solution
Clear yellow to slightly brownish solution
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the prevention and treatment of flea infestations and for the
treatment of biting lice
_(Trichodectes canis)_ on dogs of 25 kg body weight and greater.
For dogs less than 25 kg body weight, use the appropriate Advantage
for Dogs product
(see section 4.9).
Fleas on dogs are killed within one day following treatment. One
treatment prevents
further flea infestation for four weeks. The product can be used as
part of a treatment
strategy for the control of Flea Allergy Dermatitis (FAD) where this
has been previously
diagnosed by a veterinary surgeon.
4.3
CONTRAINDICATIONS
Do not treat unweaned puppies of less than 8 weeks of age.
Do not use in animals that are known to be hypersensitive to the
active substance or
any of the excipients
4.4
SPECIAL WARNINGS
None.
Page 1 of 7
Revised: October 2019
AN: 00311/2019
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
This product is for topical use and should not be administered orally.
Care should be taken to avoid the contents of the pipette coming into
contact with the
eyes or mouth of the recipient animal.
Do not allow recently treated animals to groom each other.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY
MEDICINAL PRODUCT TO ANIMALS
Wash hands thoroughly after use.
Wash off any skin contamination with soap and water.
People with known skin sensitivity may be particularly sensitive to
this product.
Avoid contact of the product with the eyes or mouth.
If the prod